Repository10.6084/m9.figshare.26621536.v1
Additional file 12 of Screening and identifying of biomarkers in early colorectal cancer and adenoma based on genome-wide methylation profiles
He Chungang,Zhong Shibiao,Chen Li Sheng,Xiao Hewei,Li, Lei +4 more
- 14 Aug 2024
Abstract: Additional file 12: Table S8. The primers of methylation markers.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
References
Cancer statistics, 2022
TL;DR: Progress has stagnated for breast and prostate cancers but strengthened for lung cancer, coinciding with changes in medical practice related to cancer screening and/or treatment, and mortality patterns reflect incidence trends.
16K
Cancer statistics in China and United States, 2022: profiles, trends, and determinants
TL;DR: Wang et al. as discussed by the authors compared the latest cancer profiles, trends, and determinants between China and USA using open-source data and calculated cancer cases and deaths in 2022 using cancer estimates from GLOBOCAN 2020 and population estimates from the United Nations.
2.5K
Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome.
Juan Sandoval,Holger Heyn,Sebastian Moran,Jordi Serra-Musach,Miguel Angel Pujana,Marina Bibikova,Manel Esteller +6 more
TL;DR: It is demonstrated that the 450K DNA methylation array can consistently and significantly detect CpG methylation changes in the H CT-116 colorectal cancer cell line in comparison with normal colon mucosa or HCT-116 cells with defective DNA methyltransferases (DKO).
1K
Epigenetics and colorectal cancer
TL;DR: Progress in the understanding of aberrant methylation in CRC has led to epigenetic alterations being developed as clinical biomarkers for diagnostic, prognostic and therapeutic applications, and it is suggested that these methylated alterations will be commonly used in the near future to direct the prevention and treatment of CRC.
Evaluation of the Infinium Methylation 450K technology.
Sarah Dedeurwaerder,Matthieu Defrance,Emilie Calonne,Hélène Denis,Christos Sotiriou,François Fuks +5 more
TL;DR: Infinium Methylation 450K is a powerful technique in terms of reagent costs, time of labor, sample throughput and coverage, and holds great promise for the better understanding of the epigenetic component in health and disease.